Impact of migraine on a personal and societal level

  • Ann I. Scher
  • Richard B. Lipton
  • Walter F. Stewart
Part of the Progress in Inflammation Research book series (PIR)


Migraine is a common, temporarily disabling, episodic disorder that affects about 28 million adults in the United States [1]. The World Health Organization classified a severe migraine attack requiring bed rest as one of the most disabling of the 30 diseases considered [2]. However, even between attacks, migraineurs live in fear that the next attack could disrupt their work, social, or family responsibilities. Thus, there is likely to be some large, but unstudied, chronic disability associated with migraine even between attacks.


Sickness Absence Migraine Headache International Headache Society Migraine Treatment Migraine Prevalence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41: 646–657PubMedCrossRefGoogle Scholar
  2. 2.
    Murray CJ, Lopez AD (1997) Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global burden of disease study. Lancet 349: 1347–1352PubMedCrossRefGoogle Scholar
  3. 3.
    Scher AI, Stewart WF, Lipton RB (1999) Migraine and headache: a meta-analytic approach. In: IK Crombie (ed): The epidemiology of pain. International Association for the Study of Pain Press, Seattle, 159–170Google Scholar
  4. 4.
    Stewart WF, Shechter A, Rasmussen BK (1994) Migraine prevalence. A review of population-based studies. Neurology 44: S17–S23PubMedGoogle Scholar
  5. 5.
    Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7): 1–96Google Scholar
  6. 6.
    Arregui A, Cabrera J, Leon-Velarde F et al (1991) High prevalence of migraine in a high-altitude population. Neurology 41: 1668–1669PubMedCrossRefGoogle Scholar
  7. 7.
    Barea LM, Tannhauser M, Rotta NT (1996) An epidemiologic study of headache among children and adolescents of southern Brazil. Cephalalgia 16: 545–549PubMedCrossRefGoogle Scholar
  8. 8.
    Cruz ME, Cruz I, Preux PM et al (1995) Headache and cysticercosis in Ecuador, South America. Headache 35: 93–97PubMedCrossRefGoogle Scholar
  9. 9.
    Jaillard AS, Mazetti P, Kala E (1997) Prevalence of migraine and headache in a high-altitude town of Peru: a population-based study. Headache 37: 95–101PubMedCrossRefGoogle Scholar
  10. 10.
    Lavados PM, Tenhamm E (1997) Epidemiology of migraine headache in Santiago, Chile: a prevalence study. Cephalalgia 17: 770–777PubMedCrossRefGoogle Scholar
  11. 11.
    Alders EE, Hentzen A, Tan CT (1996) A community-based prevalence study on headache in Malaysia. Headache 36: 379–384PubMedCrossRefGoogle Scholar
  12. 12.
    Roh JK, Kim JS, Ahn YO (1998) Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 38: 356–365PubMedCrossRefGoogle Scholar
  13. 13.
    Sakai F, Igarashi H (1997) Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17: 15–22PubMedCrossRefGoogle Scholar
  14. 14.
    Wang SJ, Liu HC, Fuh JL et al (1997) Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons. Neurology 49: 195–200PubMedCrossRefGoogle Scholar
  15. 15.
    Wang SJ, Fuh JL, Young YH (2000) Prevalence of migraine in Taipei: a population-based survey. Cephalalgia 20: 566–572PubMedCrossRefGoogle Scholar
  16. 16.
    Wong TW, Wong KS, Yu TS, Kay R (1995) Prevalence of migraine and other headaches in Hong Kong. Neuroepidemiol 14: 82–91CrossRefGoogle Scholar
  17. 17.
    Abu-Arefeh I, Russell G (1994) Prevalence of headache and migraine in schoolchildren. Br Med J 309: 765–769CrossRefGoogle Scholar
  18. 18.
    Raieli V, Raimondo D, Cammalleri R, Camarda R (1995) Migraine headaches in adolescents: a student population-based study in Montreal. Cephalalgia 15: 5–12PubMedCrossRefGoogle Scholar
  19. 19.
    Stewart WF, Linet MS, Celentano DD et al (1991) Age-and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 134: 1111–1120PubMedGoogle Scholar
  20. 20.
    Bank J, Marton S (2000) Hungarian migraine epidemiology. Headache 40: 164–169PubMedCrossRefGoogle Scholar
  21. 21.
    Bille B (1997) A 40-year follow-up of school children with migraine. Cephalalgia 17: 488–491PubMedCrossRefGoogle Scholar
  22. 22.
    Stewart WF, Lipton RB, Liberman J (1996) Variation in migraine prevalence by race. Neurology 47: 52–59PubMedCrossRefGoogle Scholar
  23. 23.
    Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. J Am Med Assoc 267: 64–69CrossRefGoogle Scholar
  24. 24.
    Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiat Res 37: 11–23CrossRefGoogle Scholar
  25. 25.
    Stewart WF, Shechter A, Lipton RB (1994) Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 44: S24–S39PubMedCrossRefGoogle Scholar
  26. 26.
    Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample (abstract). Headache 38: 404CrossRefGoogle Scholar
  27. 27.
    Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47: 871–875PubMedCrossRefGoogle Scholar
  28. 28.
    Saper JR (1990) Daily chronic headache. Neurol Clinics 8: 891–901Google Scholar
  29. 29.
    Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27: 102–106PubMedCrossRefGoogle Scholar
  30. 30.
    Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample. Headache 38: 497–506PubMedCrossRefGoogle Scholar
  31. 31.
    Michel P, Pariente P, Duru G et al (1996) MIGACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia 16: 50–55PubMedCrossRefGoogle Scholar
  32. 32.
    Van Roijen L, Essink-Bot M, Koopmanschap MA et al (1995) Societal perspective on the burden of migraine in The Netherlands. Pharmaco Economics 7: 170–179CrossRefGoogle Scholar
  33. 33.
    Merikangas KR (1991) Comorbidity of migraine and other conditions in the general-population of adults in the United States. Cephalalgia 11: 108–109Google Scholar
  34. 34.
    Essink-Bot ML, Van Royen L, Krabbe P et al (1995) The impact of migraine on health status. Headache 35: 200–206PubMedCrossRefGoogle Scholar
  35. 35.
    Breslau N, Davis GC (1993) Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiat Res 27: 211–221PubMedCrossRefGoogle Scholar
  36. 36.
    Andermann E, Andermann FA (1987) Migraine-epilepsy relationships: epidemiological and genetic aspects. In: FA Andermann, E Lugaresi (eds): Migraine and epilepsy. Butterworth-Heinemann, Boston, 281–291Google Scholar
  37. 37.
    Lipton RB, Ottman R, Ehrenberg BL, Hauser WA (1994) Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44: S28–S32PubMedCrossRefGoogle Scholar
  38. 38.
    Ottman R, Lipton RB (1994) Comorbidity of migraine and epilepsy. Neurology 44: 2105–2110PubMedCrossRefGoogle Scholar
  39. 39.
    Ottman R, Lipton RB (1996) Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology 47: 918–924PubMedCrossRefGoogle Scholar
  40. 40.
    Tzourio C, Iglesias S, Hubert JB et al (1993) Migraine and risk of ischaemic stroke: a case-control study. Br Med J 307: 89–292CrossRefGoogle Scholar
  41. 41.
    Tzourio C, Tehindrazanarivelo A, Iglesias S et al (1995) Case-control study of migraine and risk of ischaemic stroke in young women. Br Med J 310: 830–833CrossRefGoogle Scholar
  42. 42.
    Silberstein SD, Lipton RB, Breslau N (1995) Migraine: association with personality characteristics and psychopathology. Cephalalgia 15: 358–369PubMedGoogle Scholar
  43. 43.
    Merikangas KR, Angst J, Isler H (1990) Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiat 47: 849–853PubMedCrossRefGoogle Scholar
  44. 44.
    Stewart WF, Linet MS, Celentano DD (1989) Migraine headaches and panic attacks. Psychosomatic Med 51: 559–569Google Scholar
  45. 45.
    Stewart WF, Shechter A, Liberman J (1992) Physician consultation for headache pain and history of panic: results from a population-based study. Am J Med 92: S35–S40CrossRefGoogle Scholar
  46. 46.
    Merikangas KR, Stevens DE, Angst J (1993) Headache and personality: results of a community sample of young adults. J Psychiat Res 27: 187–196PubMedCrossRefGoogle Scholar
  47. 47.
    Breslau N (1992) Migraine, suicidal ideation, and suicide attempts. Neurology 42: 392–395PubMedCrossRefGoogle Scholar
  48. 48.
    Breslau N, Davis GC (1992) Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia 12: 85–90PubMedCrossRefGoogle Scholar
  49. 49.
    Breslau N, Davis GC, Schultz LR, Peterson EL (1994) Migraine and major depression: a longitudinal study. Headache 34: 387–393PubMedCrossRefGoogle Scholar
  50. 50.
    Magni G, Moreschi C, Rigatti-Luchini S, Merskey H (1994) Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain 56: 289–297PubMedCrossRefGoogle Scholar
  51. 51.
    Stang P, Von Korff M, Galer BS (1998). Reduced labor force participation among primary care patients with headache. J Gen Intern Med 13: 296–302PubMedCrossRefGoogle Scholar
  52. 52.
    Von Korff M, Le Resche L, Dworkin SF (1993) First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 55: 251–258CrossRefGoogle Scholar
  53. 53.
    Breslau N, Schultz LR, Stewart WF et al (2000) Headache and major depression: is the association specific to migraine? Neurology 54: 308–313PubMedCrossRefGoogle Scholar
  54. 54.
    Edmeads J, Findlay H, Tugwell P (1993) Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20: 131–137PubMedGoogle Scholar
  55. 55.
    Clarke CE, MacMillan L, Sondhi S, Wells NE (1996) Economic and social impact of migraine. Q J Med 89: 77–84CrossRefGoogle Scholar
  56. 56.
    Kryst S, Scherl E (1994) A population-based survey of the social and personal impact of headache. Headache 34: 344–350PubMedCrossRefGoogle Scholar
  57. 57.
    Schwartz BS, Stewart WF, Simon D, Lipton RB (1998) Epidemiology of tension-type headache. J Am Med Assoc 279: 381–383CrossRefGoogle Scholar
  58. 58.
    Göbel H, Petersen-Braun M, Soyka D (1994) The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14: 97–106PubMedCrossRefGoogle Scholar
  59. 59.
    Rasmussen BK (1992) Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol 21: 1138–1143PubMedCrossRefGoogle Scholar
  60. 60.
    O’Brien B, Goeree R, Streiner D (1994) Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 23: 1020–1026PubMedCrossRefGoogle Scholar
  61. 61.
    Pryse-Phillips W, Findlay H, Tugwell P et al (1992) A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 19: 333–339PubMedGoogle Scholar
  62. 62.
    Osuntokun BO, Adeuja AO, Nottidge VA (1992) Prevalence of headache and migrainous headache in Nigerian Africans: a community-based study. East Afr Med J 69: 196–199PubMedGoogle Scholar
  63. 63.
    Tarlov AR, Ware JEJ, Greenfield S (1989) The medical outcomes study. An application of methods for monitoring the results of medical care. J Am Med Assoc 262: 925–930CrossRefGoogle Scholar
  64. 64.
    Solomon GD, Skobieranda FG, Gragg LA (1993) Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. Headache 33: 351–358PubMedCrossRefGoogle Scholar
  65. 65.
    Osterhaus JT, Townsend RJ, Gandek B, Ware JEJ (2000) Measuring the functional status and well-being of patients with migraine headache. Headache 34:337–343CrossRefGoogle Scholar
  66. 66.
    Terwindt GM, Ferrari MD, Tijhuis M et al (1998) The impact of migraine on quality of life in the general population: the GEM study. Neurology 55: 624–629CrossRefGoogle Scholar
  67. 67.
    Lipton RB, Liberman J, Kolodner K (2000) Migraine headache disability and qualityof-life: a population-based case-control study (abstract). Headache 39: 365Google Scholar
  68. 68.
    Lipton RB, Hamelsky SW, Kolodner K et al (2000) Migraine, quality of life, and depression: a population-based case-control study. Neurology 55: 629–635PubMedCrossRefGoogle Scholar
  69. 69.
    Consumer Healthcare Products Association (2000). OTC Sales Statistics 1995–1999. AC Neilsen, Google Scholar
  70. 70.
    Hu XH, Markson LE, Lipton RB (1999) Burden of migraine in the United States — disability and economic costs. Arch Intern Med 159: 813–818PubMedCrossRefGoogle Scholar
  71. 71.
    Schappert SM (1997) Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1995. Vital health statistics. National Center for Health Statistics, Hyattsville, MarylandGoogle Scholar
  72. 72.
    Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 46: 443–446PubMedCrossRefGoogle Scholar
  73. 73.
    Schappert SM (1995) Office visits to neurologists: United States, 1991–92. Vital health statistics. National Center for Health Statistics, Hyattsville, MarylandGoogle Scholar
  74. 74.
    Forward SP, McGrath PJ, MacKinnon D et al (1998) Medication patterns of recurrent headache sufferers: a community study. Cephalalgia 18: 146–151PubMedCrossRefGoogle Scholar
  75. 75.
    Mounstephen AH, Harrison RK (1995) A study of migraine and its effects in a working population. Occupational Med 45: 311–317CrossRefGoogle Scholar
  76. 76.
    McCaig LF (2000) National hospital ambulatory medical care survey: 1998. Vital health statistics. National Center for Health Statistics, Hyattsville, MarylandGoogle Scholar
  77. 77.
    Celentano DD, Stewart WF, Lipton RB, Reed ML (1992) Medication use and disability among migraineurs: a national probability sample survey. Headache 32: 223–228PubMedCrossRefGoogle Scholar
  78. 78.
    Osterhaus JT, Gutterman DL, Plachetka JR (1992). Healthcare resource and lost labor costs of migraine headache in the US. Pharmaco Economics 2: 67–76CrossRefGoogle Scholar
  79. 79.
    Astin JA (1998) Why patients use alternative medicine: results of a national study. J Am Med Assoc 279: 1548–1553CrossRefGoogle Scholar
  80. 80.
    Eisenberg DM, Davis RB, Ettner SL (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. J Am Med Assoc 280: 1569–1575CrossRefGoogle Scholar
  81. 81.
    Feeney A, North F, Head J et al (1998) Socioeconomic and sex differentials in reason for sickness absence from the Whitehall II Study. Occupational Environmental Med 55: 91–98CrossRefGoogle Scholar
  82. 82.
    Von Korff M, Stewart WF, Simon DJ, Lipton RB (1998) Migraine and reduced work performance: a population-based diary study. Neurology 50: 1741–1745CrossRefGoogle Scholar
  83. 83.
    Michel P, Dartigues JF, Lindoulsi A, Henry P (1997) Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort. Headache 37: 71–78PubMedCrossRefGoogle Scholar
  84. 84.
    Clouse JC, Osterhaus JT (1994) Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 28: 59–664Google Scholar
  85. 85.
    Goldfarb SD, Duncan BS, Dans PE, Sloan AS (1999) HMO direct costs and health care resources use after implementation of a monthly limit on sumatriptan. Am J Health Syst Pharm 56: 2206–2210PubMedGoogle Scholar
  86. 86.
    Lipton RB, Stewart WF, Von Korff M (1997) Burden of migraine: societal costs and therapeutic opportunities. Neurology 48: S4–S9PubMedCrossRefGoogle Scholar
  87. 87.
    Streator SE, Shearer SW (1996) Pharmacoeconomic impact of injectable sumatriptan on migraine-associated healthcare costs. Am J Managed Care 2: 139–143Google Scholar
  88. 88.
    Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American migraine study. Headache 38: 87–96PubMedCrossRefGoogle Scholar
  89. 89.
    Legg RF, Sclar DA, Nemec NL et al (1997) Cost-effectiveness of sumatriptan in a managed care population. Am J Managed Care 3: 117–122Google Scholar
  90. 90.
    Lainez J.M., Titus F., Cobaleda S., Leton E (1996) Socioeconomic impact of migraine (abstract). Functional Neurol 11: 133Google Scholar
  91. 91.
    Cull RE, Wells NEJ, Miocevich ML (1992) The economic cost of migraine. Br J Med Economics 2: 103–115Google Scholar
  92. 92.
    Schwartz BS, Stewart WF, Lipton RB (1997) Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occupational Environmental Med 39: 320–327CrossRefGoogle Scholar
  93. 93.
    Stewart WF, Lipton RB, Simon D (1996) Work-related disability: results from the American migraine study. Cephalalgia 16: 231–238PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2002

Authors and Affiliations

  • Ann I. Scher
    • 1
  • Richard B. Lipton
    • 2
  • Walter F. Stewart
  1. 1.National Institutes of HealthNeuroepidemiology Branch/NINDSBethesdaUSA
  2. 2.IMRStamfordUSA

Personalised recommendations